About Vorasidenib
Class: | Antineoplastic agent, IDH inhibitor
Use: | Treatment of adult patients with recurrent or progressive glioma with an IDH1 mutation
Adult dose: | 100 mg orally once daily, taken continuously until disease progression or unacceptable toxicity
Pediatric dose: | Safety and efficacy not established in pediatric patients
Side effects: | Fatigue, nausea, vomiting, diarrhea, headache, rash, elevated liver enzymes, and potential for serious liver injury
Contraindications: | Hypersensiti
Drug Class
Antineoplastic agent, IDH inhibitor
Uses & Indications
Treatment of adult patients with recurrent or progressive glioma with an IDH1 mutation
Storage Requirements
Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F)
Manufacturer & Packaging
Manufacturer: LES LABORATOIRES SERVIER[Suresnes Cedex;France], France
Package Size
30's HDPE Bottle
Price & Supplier
Price in UAE: AED 98795.00
Dosage Information
Adult Dose
100 mg orally once daily, taken continuously until disease progression or unacceptable toxicity
Pediatric Dose
Safety and efficacy not established in pediatric patients
Side Effects
Fatigue, nausea, vomiting, diarrhea, headache, rash, elevated liver enzymes, and potential for serious liver injury
Contraindications & Precautions
Hypersensitivity to vorasidenib or any component of the formulation; severe liver impairment
Important Warnings
Risk of hepatotoxicity; monitor liver function tests prior to and during treatment; risk of serious allergic reactions; not recommended for use in patients with severe hepatic impairment
Related Medicines in Same Category
See also: Other Antineoplastic agent, IDH inhibitor medicines available in UAE pharmacies
ENASIDENIB
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.